Scaling to $500M in Revenue: ModMed CEO Daniel Cane (Part 6)

Sramana Mitra: That means architecturally, you’re going to put a recording and transcription agent on the iPad, this is not happening on the cloud, right? Daniel Cane: Right. There are several reasons for this approach. First and foremost, it’s about performance and latency. By keeping everything on the device, we’re minimizing the amount of information

Read Full Article »

Scaling to $500M in Revenue: ModMed CEO Daniel Cane (Part 5)

Sramana Mitra: Double click down for me on the AI aspect. I know you were doing AI right up front, but of course, AI has evolved. The market has evolved. Market’s receptivity to AI has evolved. AI has come of age, so to speak in the last fifteen years. Where are you with AI? What

Read Full Article »

Scaling to $500M in Revenue: ModMed CEO Daniel Cane (Part 4)

Sramana Mitra: What has driven the choices of which specialty to go on to next? Daniel Cane: There are several factors we consider when entering a new specialty. The primary question is: where is there a large, underserved population of dissatisfied physicians?

Scaling to $500M in Revenue: ModMed CEO Daniel Cane (Part 3)

Sramana Mitra: I purposely actually picked to highlight the positioning points where you can differentiate it versus areas where you cannot really differentiate. The domain of billing is less of a big differentiation in ModMed. The bigger differentiation is in the specialty specific content, specialty specific workflow and specialty specific treatment, right?

Scaling to $500M in Revenue: ModMed CEO Daniel Cane (Part 2)

Sramana Mitra: Okay. So that’s one positioning differentiation. What about within the private practice market? Why do your customers pick you and what is special about it? What are the needs of a dermatology private practice or an OB-GYN practice or a plastic surgery practice? What’s special about each of these individual types of practices?

Scaling to $500M in Revenue: ModMed CEO Daniel Cane (Part 1)

I first spoke with Dan a decade back. Here is the story. This conversation offers insights on his scaling strategy with ModMed.

Bootstrapping to Exit, Then Raise Money and Exit Again: Wendy CEO Lance Neuhauser (Part 7)

Sramana Mitra: So, if you’re comfortable disclosing, how much money did you raise during that ten-year period from 2010-2020, and what kind of exit did you get, numerically? Lance Newhauser: We ended up raising about $35 million for 4C specifically from 2010 to 2020. There was some debt layered on top of that as well.

Read Full Article »

Bootstrapping to Exit, Then Raise Money and Exit Again: Wendy CEO Lance Neuhauser (Part 6)

Sramana Mitra: How did you address this complex sales cycle issue? Because that could really block velocity.